Authors: Rafi, I

Citation: I. Rafi, Inhaled corticosteroids and bone density, LANCET, 356(9227), 2000, pp. 426-426

Authors: Hughes, AN Rafi, I Griffin, MJ Calvert, AH Newell, DR Calvete, JA Johnston, A Clendeninn, N Boddy, AV

Citation: An. Hughes et al., Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days, CLIN CANC R, 5(1), 1999, pp. 111-118

Authors: Jodrell, DI Bowman, A Rye, R Byrne, B Boddy, A Rafi, I Taylor, GA Johnston, A Clendeninn, NJ

Citation: Di. Jodrell et al., A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (TM) (nolatrexed dihydrochloride) given by 10-day oral administration, BR J CANC, 79(5-6), 1999, pp. 915-920